Ayana Bio Awarded National Institutes of Health Grant to Harness Neuroprotective Benefits from Plant Cell-Cultivated Saffron [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
BOSTON May 1, 2024 /PRNewswire/ -- Ayana Bio , the plant cell technology company dedicated to creating sustainable bioactives for consumer products, has received a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to support Ayana Bio's research into the production of saffron's neuroprotective bioactives through plant cell cultivation. Clinical studies demonstrate saffron's beneficial effects across a range of neurological and age-related diseases, such as depression , anxiety and Alzheimer's disease. Saffron's neurological effects are also proven to aid in weight loss by increasing satiety , making it a powerful health ingredient with interconnected benefits. The $300 thousand NIH grant will fund Ayana Bio's research to identify which complex of saffron bioactives can consistently demonstrate the highest neuroprotective benefits, specifically for Huntington's disease. The company will use its high-th
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target lowered by analysts at Morgan Stanley from $2.00 to $1.00. They now have an "equal weight" rating on the stock.MarketBeat
- What's the Difference Between Biotech Stocks and TechBio Stocks? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) was downgraded by analysts at BTIG Research from a "neutral" rating to a "sell" rating.MarketBeat
- Ginkgo Bioworks to Participate in Two Conferences in May [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks to Participate in Two Conferences in MayPR Newswire
DNA
Earnings
- 5/9/24 - In-Line
DNA
Sec Filings
- 5/15/24 - Form 144
- 5/14/24 - Form 4
- 5/14/24 - Form 4
- DNA's page on the SEC website